ANI Pharmaceuticals ANIP Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $311.21M+108% | $285.62M+97.1% | $262.65M+81.1% | $217.83M-9.3% | $149.84M-34.5% | ||
| $255.43M+15.9% | $281.08M+26.8% | $252.62M+28.6% | $225.65M+35.9% | $220.33M+27.8% | ||
| $143.47M+4.4% | $143.07M+4.6% | $146.48M-1.1% | $138.32M+10.3% | $137.41M+20.7% | ||
| $747.08M+39.3% | $753.12M+42.5% | $698.4M+34.0% | $602.63M+8.5% | $536.29M-0.8% | ||
| $67.12M+15.4% | $62.48M+9.9% | $63.56M+12.1% | $59.25M+14.7% | $58.18M+19.9% | ||
| $62.48M+3.0% | $62.48M+4.2% | $62.48M+3.4% | $60.53M+114% | $60.66M+115% | ||
| $467.16M-10.6% | $479.53M-11.5% | $499.82M-9.1% | $520.32M+219% | $522.7M+197% | ||
| $1.42B+10.0% | $1.44B+12.1% | $1.41B+9.4% | $1.34B+45.9% | $1.29B+41.3% | ||
| $69.69M+31.4% | $62.58M+37.1% | $69.8M+14.6% | $54.57M+12.1% | $53.06M+7.3% | ||
| $19.3M+72.4% | $17.27M+88.3% | $15.24M+113% | $13.22M+1,455% | $11.19M+1,217% | ||
| $239.51M+18.7% | $278.11M+43.0% | $270.56M+42.4% | $236.84M+69.2% | $201.82M+47.4% | ||
| $286M-6.3% | $291.84M-5.6% | $297.68M-4.9% | $301.48M+6.0% | $305.29M+7.3% | ||
| $859.67M+1.3% | $899.65M+5.1% | $902.34M+5.3% | $881.39M+100% | $848.96M+94.0% | ||
| $3K+50.0% | $3K+50.0% | $3K+50.0% | $2K0.0% | $2K0.0% | ||
| $6.39M+108% | -$23.1M+77.0% | -$50.59M+43.5% | -$76.86M-18.2% | -$85M-36.4% | ||
| $562.3M+34.3% | $540.72M+33.9% | $505.82M+24.6% | $436.76M-4.2% | $418.62M-7.4% | ||
| $1.42B+10.0% | $1.44B+12.1% | $1.41B+9.4% | $1.34B+45.9% | $1.29B+41.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are ANI Pharmaceuticals's total assets?
- ANI Pharmaceuticals (ANIP) holds $1.4B in total assets, up 10.0% year over year.
- How much debt does ANI Pharmaceuticals have?
- ANI Pharmaceuticals carries $305.3M in total debt against $562.3M of shareholders' equity, a debt-to-equity ratio of 0.54.
- How much cash does ANI Pharmaceuticals have?
- ANI Pharmaceuticals holds $311.2M in cash and equivalents.
- Can ANI Pharmaceuticals cover its short-term obligations?
- Its current ratio is 3.12 — current assets exceed current liabilities.
- Where does ANI Pharmaceuticals's balance sheet data come from?
- Every line is extracted from ANI Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
